Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6477-6489

  Shultz, Leonard D ^a   Lyons, Bonnie L ^a   Burzenski, Lisa M ^a   Gott, Bruce ^a   Chen, Xiaohua ^b   Chaleff, Stanley ^b   Kotb, Malak ^c   Gillies, Stephen D ^d   King, Marie ^e   Mangada, Julie ^e   Greiner, Dale L ^e   Handgretinger, Rupert ^b  

^a JACKSON LABORATORY   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d EMD SERONO INC   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 2 RECEPTOR GAMMA; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOID CELL; LYMPHOMA; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; THYMOCYTE;

EID: 20844434966     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6477     Document Type: Article

References (72)

1. Schmitz, N., and J. Barrett. 2002. Optimizing engraftment: source and dose of stem cells. Semin. Hematol. 39: 314.
2. Quesenberry, P. J. 1991. The blueness of stem cells. Exp. Hematol. 19: 725-728.
3. Benito, A. I., M. A. Diaz, M. Gonzalez-Vicent, J. Sevilla, and L. Madero. 2004. Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant. 33: 675-690.
4. + progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant. 27: 777-783.
5. Krejci, M., T. Buchler, R. Hajek, A. Svobodnik, A. Krivanova, L. Pour, Z. Adam, J. Mayer, and J. Vorlicek. 2004. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow Transplant. 35: 159-164.
6. Krivit, W., and C. B. Whitley. 1987. Bone marrow transplantation for genetic diseases. N. Engl. J. Med. 316: 1085-1087.
7. van Bekkum, D. W. 2004. Stem cell transplantation for autoimmune disorders: preclinical experiments. Best Pract. Res. Clin. Haematol. 17: 201-222.
8. McCune, J., H. Kaneshima, J. Krowka, R. Namikawa, H. Outzen, B. Peault, L. Rabin, C. Shih, E. Lee, M. Lieberman, I. Weissman, and L. D. Shultz. 1991. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu. Rev. Immunol. 9: 399-429.
9. Lapidot, T., F. Pfluraio, M. Deodens, B. Murdoch, D. E. Williams, and J. E. Dick. 1992. Cytokine stimulation of multi lineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255: 1137-1141.
10. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol 154: 180-191.
11. Serreze, D. V., H. R. Gaskins, and E. H. Leiter. 1993. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 150: 2534-2543.
12. Serreze, D. V., J. W. Gaedeke, and E. H. Leiter. 1993. Hematopoietic stem cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. USA 90: 9625-9629.
13. Langmuir, P., M. Bridgett, A. Bothwell, and I. Crispe. 1993. Bone marrow abnormalities in the non-obese diabetic mouse. Int. Immunol. 5: 169-177.
14. Greiner, D. L., R. A. Hesselton, and L. D. Shultz. 1998. SCID mouse models of human stem cell engraftment. Stem Cells 16: 166-177.
15. + T cell engraftment in β2-microglobulin-deficient NOD-scid mice. J. Immunol. 158: 3578-3586.
16. null) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95: 3102-3105.
17. 2-microglobulin-null mice. J. Clin. Invest. 107: 199-206.
18. null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol 164: 2496-2507.
19. null mice: a new model system to increase levels of human peripheral leukocyte and hematopoietic stem cell engraftment. Transplantation 76; 1036-1042.
20. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronz, S. C. Piffaretti, A. Lanzavecchia, and M. G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107.
21. null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
22. null mice. J. Immunol. 169: 204-209.
23. Uribe, L. and K. I. Weinberg. 1998. X-linked SCID and other defects of cytokine pathways. Semin. Hematol. 35: 299-309.
24. Sugamura, K., H. Asao, M. Kondo, N. Tanaka. N. Ishii, K. Ohbo, M. Nakamura, and T. Takeshita. 1996. The interleukin-2 receptor γ chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14: 179-205.
25. Asao, H., C. Okuyama, S. Kumaki, N. Ishii, S. Tsuchiya, D. Foster, and K. Sugamura. 2001. Cutting edge: the common γ-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 167: 1-13.
26. Cao, X., E. W. Shores, J. Hu-Li, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2: 223-238.
27. Araki, R., A. Fujimori, K. Hamatani, K. Mita, T. Saito, M. Mori, R. Fukumura, M. Morimyo, M. Muto, M. Itoh, K. Tatsumi, and M. Abe. 1997. Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc. Natl. Acad. Sci. USA 94: 2438-2443.
28. Heid, C. A., J. Stevens, K. J. Livak, and P. M. Williams. 1996. Real time quantitative PCR. Genome Res. 6: 986-994.
29. Lyons, B. L., M. A. Lynes, L. Burzenski, M. I. Joliat, N. Hadjout, and L. D. Shultz. 2003. Mechanisms of anemia in SHP-I protein tyrosine phosphatase-deficient "viable motheaten" mice. Exp. Hematol. 31: 234-243.
30. Lillie, R. D. 1954. Histopathology Technique and Practical Histochemistry. Blakiston Press, New York.
31. Pearson, T., T. G. Markees, D. V. Serreze, M. A. Pierce, M. P. Marron, L. S. Wicker, L. B. Peterson, L. D. Shultz, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2003. Genetic disassociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice. J. Immunol. 171: 185-195.
32. + cells using the CliniMACS device. J. Hematother. 8: 209-218.
33. Lo, K. M., Y. Sudo, J. Chen, Y. Li, Y. Lan, S. M. Kong, L. Chen, Q. An, and S. D. Gillies. 1998. High level expression and secretion of Fc-X fusion proteins in mammalian cells. Protein Eng. 11: 495-500.
34. Hazenberg, M. D., S. A. Otto, J. W. Cohen Stuart, M. C. Verschuren, J. C. Borleffs, C. A. Boucher, R. A. Coutinho, J. M. Lange, T. F. Rinke de Wit, A. Tsegaye, et al. 2000. Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat. Med. 6: 1036-1042.
35. Chen, X., R. Barfield, E. Benaim, W. Leung, J. Knowles, D. Lawrence, M. Otto, S. A. Shurtleff. G. A. Neale, F. G. Behm, V. Turner, and R. Handgretinger. 2005. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 105: 886-893.
36. Gorski, J., T. Piatek, M. Yassai, and K. Maslanka. 1995. Improvements in repertoire analysis by CDR3 size spectratyping: bifamily PCR. Ann. NY Acad. Sci. 756: 99-102.
37. Wu, C. J., A. Chillemi, E. P. Alyea, E. Orsini, D. Neuberg, R. J. Soiffer, and J. Ritz. 2000. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood 95: 352-359.
38. Kaplan, E., and P. Meier. 1958. Nonparametric estimation from incomplete observations. J. Am. Statist. Assn. 53: 457-481.
39. Matthews, D., and D. Farewell. 1988. The log-rank or Mantel-Haenzel test for the comparison of survival curves. In Using and Understanding Medical Statistics. D. Matthews and V. Farewell, eds. Karger, Basel, p. 79-87.
40. Meyerrose, T. E., P. Herrbrich, D. A. Hess, and J. A. Nolta. 2003. Immunedeficient mouse models for analysis of human stem cells. Biotechniques 35: 1262-1272.
41. Murphy, W. J., S. K. Durum, M. R. Anver, D. K. Ferris, D. W. McVicar, J. J. O'Shea, S. K. Ruscetti, M. R. Smith, H. A. Young, and D. L. Longo. 1994. Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID). J. Immunol. 153: 1004-1014.
42. Danska, J. S., F. Pflumio, C. J. Williams, O. Huner, J. E. Dick, and C. J. Guidos. 1994. Rescue of T cell-specific V(D)J recombination in SCID mice by DNA-damaging agents. Science 266: 450-455.
43. Martina, C., J. Wayne, A. Bell, and Y. Chang. 2003. In vivo ligation of CD3 on neonatal seid thymocytes blocks γ-irradiation-induced TCRβ rearrangements and thymic lymphomagenesis. Immunol Lett. 85: 279-286.
44. Bosma, G. C., M. Fried, R. P. Custer, A. Carroll, D. M. Gibson, and M. J. Bosma. 1988. Evidence of functional lymphocytes in some (leaky) scid mice. J. Exp. Med. 167: 1016-1033.
45. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695.
46. Pannetier, C., M. Cochet, S. Darche, A. Casrouge, M. Zoller, and P. Kourilsky. 1993. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA 90: 4319-4323.
47. Maslanka, K., T. Piatek, J. Gorski, and M. Yassai. 1995. Molecular analysis of T cell repertoires: spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence. Hum. Immunol. 44: 28-34.
48. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky. 1999. A direct estimate of the human αβ T cell receptor diversity. Science 286: 958-961.
49. Yui, M. A., and E. V. Rothenberg. 2004. Deranged early T cell development in immunodeficient strains of nonobese diabetic mice. J. Immunol. 173: 5381-5391.
50. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Letter. 1992. The NOD-scid mouse: a model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89: 3290.
51. null NOD-scid mice: an improved host for adoptive transfer of autoimmune diabetes and growth of human lymphohematopoietic cells. Diabetes 44: 1392-1398.
52. Chiu, P. P., E. Ivakine, S. Mortin-Toth, and J. S. Danska. 2002. Susceptibility to lymphoid neuplasia in immunodeficient strains of nonobese diabetic mice. Cancer Res. 62: 5828-5834.
53. DiSanto, J. P., W. Muller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. USA 92: 377-381.
54. Ohbo, K., T. Suda, M. Hashiyama, A. Mantani, M. Ikebe, K. Miyakawa, M. Moriyama, M. Nakamura, M. Katsuki, K. Takahashi, K. Yamamura, and K. Sugamura. 1996. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain. Blood 87: 956-967.
55. null mice model. Blood 102: 873-880.
56. + cells. Exp. Hematol. 31: 789-797.
57. Hesselton, R. M., D. L. Greiner, J. P. Mordes, T. V. Rajan, J. L. Sullivan, and L. D. Shultz. 1995. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to HIV-1 infection in NOD/LtSz-scid/scid mice. J. Infect. Dis. 172: 974-982.
58. Larochelle, A., J. Vormoor, T. Lapidot, G. Sher, T. Furukawa, Q. Li, L. D. Shultz, N. F. Olivieri, G. Stamatoyannopoulos, and J. E. Dick. 1995. Engraftment of immune-deficient mice with primitive hematopoietic cells from β-thalassemia and sickle cell anemia patients: implications for evaluating human gene therapy protocols. Hum. Mol. Genet. 4: 163-172.
59. Greiner, D. L., and L. D. Shultz. 1998. The Use of NOD/LtSz-scid/scid mice in biomedical research. In NOD Mice and Related Strains: Research Applications in Diabetes, AIDS, Cancer and Other Diseases. E. Leiter and M. Atkinson, eds. Landes Bioscience, Austin. pp. 179-203.
60. Ballen, K. K., H. Valinski, D. Greiner, L. D. Shultz, P. S. Becker, C. C. Hsieh, F. M. Stewart, and P. J. Quesenberry. 2001. Variables to predict engraftment of umbilical cord blood into immunodeficient mice: usefulness of the non-obese diabetic-severe combined immunodeficient assay. Br. J. Haematol. 114: 211-218.
61. van der Loo, J, C., H. Hanenberg, R. J. Cooper, F. Y. Luo, E. N. Lazaridis, and D. A. Williams. 1998. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood 92: 2556-2570.
62. Wang, J. C., M. Doedens, and J. E. Dick. 1997. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89: 3919-3924.
63. + cells from umbilical cord blood as compared to adult sources. Bone Marrow Transplant. 28: 163-171.
64. El Kassar, N., P. J. Lucas, D. B. Klug, M. Zamisch, M. Merchant, C. V. Bare, B. Choudhury, S. O. Sharrow, E. Richie, C. L. Mackall, and R. E. Gress. 2004. A dose effect of IL-7 on thymocyte development. Blood 104: 1419-1427.
65. von Freeden-Jeffry, U., N. Solvason, M. Howard, and R. Murray. 1997. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7: 147-154.
66. von Freeden-Jeffry, U., P. Vieira, L. A. Lucian, T. McNeil, S. E. Burdach, and R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181: 1519-1526.
67. Gillies, S. D., D. Young, K. M. Lo, and S. Roberts. 1993. Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins. Bioconjug. Chem. 4: 230-235.
68. Wagar, E. J., M. A. Cromwell, L. D. Shultz, B. A. Woda, J. L. Sullivan, R. M. Hessetton, and D. L. Greiner. 2000. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J. Immunol. 165: 518-527.
69. Samaridis, J., G. Casorati, A. Traunecker, A. Iglesias, J. C. Gutierrez, U. Muller, and R. Palacios. 1991. Development of lymphocytes in interleukin 7-transgenic mice. Eur. J. Immunol. 21: 453-460.
70. Rich, B. E., J. Campos-Torres, R. I. Tepper, R. W. Moreadith, and P. Leder. 1993. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J. Exp. Med. 177: 305-316.
71. Mertsching, E., U. Grawunder, V. Meyer, T. Rolink, and R. Ceredig. 1996. Phenotypic and functional analysis of B lymphopoiesis in interleukin-7- transgenic mice: expansion of pro/pre-B cell number and persistence of B lymphocyte development in lymph nodes and spleen. Eur. J. Immunol. 26: 28-33.
72. null mice. Blood in press.